Type 1 diabetes (also known as diabetes mellitus) is an autoimmune disease in which immune cells attack and destroy the insulin-producing cells of the pancreas. The loss of insulin leads to the ...

The 2.7mg dose is also being evaluated in the Phase 3 pivotal trials for wet age-related macular degeneration. Duravyu 2.7mg demonstrated an early and sustained improvement in BCVA and central ...

Rosiglitazone is a drug used to help people with type 2 diabetes control their blood sugar levels. Belonging to a class of drugs called thiazolidinediones, it was initially seen as a promising ...

Researchers have discovered that semaglutide, a diabetes and weight-loss medication sold under the brand names Wegovy and Ozempic, might significantly reduce the risk of Alzheimer’s in type 2 diabetes ...

While semaglutide is well-known as a diabetes and weight-loss drug, this study shows it might also help protect the kidneys, making it a potential game-changer for people with chronic kidney disease.

Semaglutide, the diabetes drug also known as Ozempic, has shown positive effects in treating patients with chronic kidney disease (CKD) and obesity, as revealed in an international study led by ...

The diabetes drug semaglutide, also known as Ozempic, has a positive effect for patients with chronic kidney damage and obesity. They have less protein in their urine, less inflammation in their ...

Treatments for mental health conditions are structured around the condition being treated and typically are holistic in nature- including not just medication but also other interventions, such as ...

Some diabetes patients this year have had trouble finding their preferred insulin brands as major drug manufacturers reported shortages of the medicine. USA TODAY set out to find out what patients ...

Novo Nordisk's blockbuster diabetes drug Ozempic may reduce the risk of developing Alzheimer's disease, according to a new analysis of electronic health records. The findings suggest that Ozempic ...